Aug 12, 2020 | Press Release
Wilmington, NC, 12 August 2020 – For the first time, Wilmington-headquartered Catalyst Clinical Research appears on the Inc. 5000 list of fastest-growing private companies in America. Catalyst ranked 1235 on the list. Recognition on the Inc. 5000 list echoes...
Aug 5, 2020 | Press Release
Wilmington, NC, 4 August 2020 – Catalyst Clinical Research announced today that it has merged with Ce3, Inc. to expand its depth of oncology-specific therapeutic expertise. The combined company is strongly positioned to deliver oncology clinical development services...
Jun 11, 2020 | Press Release
Wilmington, NC, 12 June 2020 – Catalyst Clinical Research, a Wilmington-based award-winning clinical development and global resourcing organization, announced the hiring of Andrew Zupnick, PhD as Vice President of Oncology Drug Development. Dr. Zupnick will be...
May 12, 2020 | Press Release
Wilmington, NC, 13 May 2020 – Catalyst Clinical Research, a clinical development and global resourcing organization headquartered in Wilmington, NC, recently announced the hiring of Melissa Church as Chief Strategy Officer. Church will be leading the Marketing,...
Apr 30, 2020 | Press Release
Wilmington, NC, 1 May 2020 – Recognition as a recipient of the CRO Leadership Awards reflects Catalyst’s growing customer base, expanding solutions and continuation of its flexible, high quality service delivery model. Named among four categories presented by Life...
Mar 5, 2019 | Press Release
Durham, NC (March 5, 2019) – Catalyst Clinical Research, LLC (“Catalyst”), a leading provider of therapeutically-aligned, operational experts to pharmaceutical, biotechnology, and medical device companies in clinical development, acquired certain assets of...
